Navigation Links
Fact Sheet: Advancing Stem Cell Research While Respecting Moral,Boundaries

been destroyed before the President's policy was announced. It has also provided more than $3 billion in Federal funding for research on all forms of stem cells, including those from adult and other non-embryonic sources. This funding has contributed to proven therapeutic treatments in thousands of patients with many different diseases, and it is opening the prospect of new treatments and cures that could transform countless lives.

Recent Scientific Breakthroughs Are Showing Stem Cell Science Can Progress While Respecting Moral Boundaries

There Have Been Advances In Therapies That Use Stem Cells Drawn From Adults, Children, And The Blood From Umbilical Cords - With No Harm To The Donor.

Researchers Are Now Developing Promising New Techniques That Offer The Potential To Produce Pluripotent Stem Cells - Without Having To Destroy Human Life.

-- This month, several new studies showed the potential of reprogramming adult cells, such as skin cells, to make them function like embryonic stem cells.

-- In January 2007, scientists discovered that cells extracted from amniotic fluid and placentas could also provide stem cells that seem to do what embryonic stem cells can - without creating or destroying embryos.

The Administration Is Taking Immediate Action To Increase Our Support For These Researchers In Their Vital Work

Today, President Bush Issued An Executive Order To Strengthen Our Nation's Commitment To Research On Pluripotent Stem Cells. The Order:

-- Directs the Department of Health and Human Services and the National Institutes of Health to ensure that any human pluripotent stem cell lines produced in ways that do not create, destroy, or harm human embryos will be eligible for federal funding.

-- Expands the NIH's Embryonic Stem Cell registry to include all types of ethically produced human pluripotent stem cells.

-- Renames the registry the Pluripotent Stem Cell Registry - so that it reflects what
'"/>




Page: 1 2 3

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. Researchers Discover Method for Identifying How Cancer Evades the Immune System
6. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
7. President Bush Ignores Americas Plea for Support of Stem Cell Research
8. Researchers Discover Gene For Rare Skin Disorder
9. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
10. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
11. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
Post Your Comments:
(Date:12/2/2008)...if., Dec. 2 TorreyPines Therapeuti...e results from a 26 patient Phase II trial evaluat...tomia, or dry mouth, in patients with Sjogren,s sy...istically significant increase in salivary flow pr...0 mg, 15 mg, and 20 mg. These doses were safe and ...
(Date:12/2/2008)... Dec. 2 Horizon Therapeutics, Inc....ay announced that two pivotal,Phase 3 trials eval... HZT-501,met all primary endpoints. HZT-501, a n...containing ibuprofen and famotidine, demonstrated ...dence of non-steroidal,anti-inflammatory drug (NS...
(Date:12/2/2008)..., Dec. 2 Micromet, Inc. ...eloping novel, proprietary antibodies for the trea...ses, today announced that it has entered into an a...Facility (CEFF) with Kingsbridge Capital Limited, ...e agreement, Kingsbridge has committed to provide ...
(Date:12/1/2008)... 2 New research has fou... computed tomography (CT) scanner in an emergency ...ke victims who receive a potentially life-saving t... Shore Medical Center (NSMC)-Salem Hospital in Sal...eeting of the Radiological Society of North Americ...
Breaking Medicine Technology:TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3NCPA Applauds U S House Vote in Favor of H R 6331 22698 1New Aptivus 28R 29 28tipranavir 29 Oral Solution Approved for Treatment Experienced Pediatric and Adolescent HIV Patients 6198 1New Aptivus 28R 29 28tipranavir 29 Oral Solution Approved for Treatment Experienced Pediatric and Adolescent HIV Patients 6198 2New Aptivus 28R 29 28tipranavir 29 Oral Solution Approved for Treatment Experienced Pediatric and Adolescent HIV Patients 6198 3New Aptivus 28R 29 28tipranavir 29 Oral Solution Approved for Treatment Experienced Pediatric and Adolescent HIV Patients 6198 4New Aptivus 28R 29 28tipranavir 29 Oral Solution Approved for Treatment Experienced Pediatric and Adolescent HIV Patients 6198 5New Aptivus 28R 29 28tipranavir 29 Oral Solution Approved for Treatment Experienced Pediatric and Adolescent HIV Patients 6198 6New Aptivus 28R 29 28tipranavir 29 Oral Solution Approved for Treatment Experienced Pediatric and Adolescent HIV Patients 6198 7New Aptivus 28R 29 28tipranavir 29 Oral Solution Approved for Treatment Experienced Pediatric and Adolescent HIV Patients 6198 8New Aptivus 28R 29 28tipranavir 29 Oral Solution Approved for Treatment Experienced Pediatric and Adolescent HIV Patients 6198 9Drug Coated Stents Reduce Repeat Artery Procedures 22693 1Drug Coated Stents Reduce Repeat Artery Procedures 22693 2Drug Coated Stents Reduce Repeat Artery Procedures 22693 3Certain anti cancer agents could be harmful to patients with heart disease 22689 1Certain anti cancer agents could be harmful to patients with heart disease 22689 2Certain anti cancer agents could be harmful to patients with heart disease 22689 3
...ON VALLEY, Pa.--(BUSINESS WIRE)--Apr 12, 2007 - Im...at the American,Association for Cancer Research (A...5 to 18. The Company will feature,Immunicon Pharma...at Kit and the new EasyCount(TM) System at booth 1...opment and clinical,trial testing services to some...
...c found to dramatically reduce the risk of cancer,...estinal stromal,tumors (GIST) , * Patients receivi...c , * Global regulatory submissions planned for us...ollowing surgery to remove,primary tumor , * Glive...ts with,advanced metastatic or inoperable Kit-posi...
Other Medicine Technology:Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR 2Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR 3Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 2Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 3Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 5Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 6
(Date:12/2/2008)... Zicam Cold & Flu Companion uses loca...tep ahead of cold and flu. , ...Matrixx Initiatives, Inc., makers of Zicam® Co...® Cold & Flu Companion mobile application ...oid-powered phone. The same mobile application wil...
(Date:12/2/2008)...Call to Action Highlights Need to Reduce Dispariti...nal Efforts , , BETHESDA, Md., Dec. 2 /PRN...s Diseases, (NFID) S.T.O.P. (Share. Teach. Outre...f many of the nation,s leading medical and advocac...to improve adolescent meningococcal vaccination ra...
(Date:12/2/2008)...Dec. 2 MedPro Imaging, a premier p... announced the appointment of three,new ultrasoun... aggressive,expansion. The company also announce...cilities due to substantial growth throughout 2008...e president of Sales and Marketing in,February of...
(Date:12/2/2008)...wellness services available to seniors , , ... Alliance Plan (HAP) is adding acupuncture and chi...Benefit for Medicare Advantage members beginning J...promote wellness encourages Medicare beneficiaries...e putting money back in their wallets. , , ...
Breaking Medicine News(10 mins):Health News:Zicam Launches "Cold & Flu Companion" Mobile Application 2Health News:Zicam Launches "Cold & Flu Companion" Mobile Application 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:MedPro Imaging Continues Aggressive U.S. Expansion 2Health News:HAP Expands Medicare Advantage Options to Include Acupuncture and Chiropractic Services 2Health News:HAP Expands Medicare Advantage Options to Include Acupuncture and Chiropractic Services 3
...tes in the US are stepping up their efforts to for...ds of mercury emissions.// Throughout the Northe...alth concern. Mercury is a metal that occurs natur...seous form when coal is burned in electrical gener...
...in Rajasthan - is all set to travel to war-hit Leb...ts from the Bhagwan Mahaveer Viklang Sahayta Samit...vitation of the Indian contingent of the UN peacek...SS general secretary S.R. Mehta said. The team w...
...stakes made by medical secretaries in India have b...h hospitals// from being outsourced to India and t...tional Health Service (NHS) have outsourced medica...re considering the option to cut budgetary deficit...
...disease in western Bangladesh's Kushtia district i...ng people// as the number of patients rises everyd... more than 50 people are being treated at the hosp...ents is growing day by day, The Daily Star reporte...
Other Medicine News:Health News:US States Get Ready to Fight Mercury Pollution 2Health News:Jaipur Foot Takes Off for Lebanon 2Health News:Outsourcing of UK Hospital Records to India Opposed 2
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: